Clinical Efficacy of Laser Combined with Menstrual Regulation in the Treatment of Female Melasma: a Retrospective Study

Overview

Journal Lasers Med Sci

Publisher Springer

Date 2019 Jan 9

PMID 30617662

Citations 1

Authors

Yu Jin

Wenbo Jiang

Yonghui Yao

Huang Huang

Jinlong Huang

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to evaluate the clinical efficacy of using a Medlite C6 Q-switch Nd:YAG laser combined with menstrual regulation-based traditional Chinese medicine (TCM) in the treatment of female melasma. Forty cases of female patients with melasma, who were treated between December 2013 and December 2015 at the Jiangsu Provincial Hospital of Traditional Chinese Medicine, were reviewed retrospectively. Twenty patients received Q-switch Nd:YAG 1064 nm laser treatments combined with menstrual regulation treatments (experimental group), and 20 patients were treated only with the laser (control group). All treatments lasted for 6 months. The patients' faces were photographed before, immediately, and 6 months after treatment. The therapeutic efficacy was assessed by the reduction in the Melasma Area and Severity Index (MASI) score and the total skin damage score, and this was then compared between the two groups. Immediately and 6 months after the treatment, both the MASI and total skin damage scores in the experimental group were significantly lower compared to those in the control group (P < 0.001). The experimental group had significantly higher basic recovery and effectiveness rates than the control group (P = 0.020 and P = 0.008, respectively) and had a significantly lower invalidity rate (P < 0.001). Results from Medlite C6 Q-switch Nd:YAG laser treatment combined with menstrual regulation are superior than those obtained using only a laser for the treatment of female melasma.

Citing Articles

Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.

Abd Elraouf I, Obaid Z, Fouda I Arch Dermatol Res. 2023; 315(6):1763-1770.

PMID: 36856856 PMC: 10338558. DOI: 10.1007/s00403-023-02580-y.

References

Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J . Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg. 1999; 25(6):494-7. DOI: 10.1046/j.1524-4725.1999.08248.x. View

Angsuwarangsee S, Polnikorn N . Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg. 2003; 29(1):59-64. DOI: 10.1046/j.1524-4725.2003.29009.x. View

SNELL R, BISCHITZ P . The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol. 1960; 35:73-82. DOI: 10.1038/jid.1960.87. View

Wu Y, Li Q, Yang X . Effects of Chinese herbal medicine combined with He-Ne laser on lipoperoxide and superoxide dismutase in chloasma patients. J Tradit Chin Med. 2009; 29(3):163-6. DOI: 10.1016/s0254-6272(09)60056-x. View

Wattanakrai P, Mornchan R, Eimpunth S . Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010; 36(1):76-87. DOI: 10.1111/j.1524-4725.2009.01383.x. View

Suh K, Sung J, Roh H, Jeon Y, Kim Y, Kim S . Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma. J Dermatolog Treat. 2010; 22(4):233-8. DOI: 10.3109/09546631003686051. View

Choi M, Choi J, Lee S, Choi S, Park H, Park K . Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma. J Dermatolog Treat. 2010; 21(4):224-8. DOI: 10.3109/09546630903401462. View

Zhou X, Gold M, Lu Z, Li Y . Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatol Surg. 2011; 37(7):962-70. DOI: 10.1111/j.1524-4725.2011.02001.x. View

Kauvar A . Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers. Lasers Surg Med. 2012; 44(2):117-24. DOI: 10.1002/lsm.21156. View

10.

Yan-Hua C, Fang L, Shi N . [Clinical effects of shen-nourishing and menstruation-regulating method combined with triptorelin acetate injection on patient with luteinized unruptured follicle syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012; 31(12):1604-6. View

11.

Kar H, Gupta L, Chauhan A . A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma. Indian J Dermatol Venereol Leprol. 2012; 78(2):165-71. DOI: 10.4103/0378-6323.93633. View

12.

Sim J, Park Y, Lee J, Lee S, Choi W, Kim H . Treatment of melasma by low-fluence 1064 nm Q-switched Nd:YAG laser. J Dermatolog Treat. 2012; 25(3):212-7. DOI: 10.3109/09546634.2012.735639. View

13.

Shin J, Park J, Oh S, Lee J . Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial. Dermatol Surg. 2013; 39(3 Pt 1):435-42. DOI: 10.1111/dsu.12060. View

14.

Bansal C, Naik H, Kar H, Chauhan A . A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients. J Cutan Aesthet Surg. 2013; 5(4):266-72. PMC: 3560167. DOI: 10.4103/0974-2077.104915. View

15.

Huang X, Liang S, Wang L . [Treatment of declining in ovarian reserve by shen-reinforcing and menstrual cycle-regulating therapy combined with western medicine: a clinical observation]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014; 34(6):688-90. View

16.

Vachiramon V, Sirithanabadeekul P, Sahawatwong S . Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma. J Eur Acad Dermatol Venereol. 2014; 29(7):1339-46. DOI: 10.1111/jdv.12854. View

17.

Hofbauer Parra C, Careta M, Valente N, de Sanches Osorio N, Torezan L . Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser. Dermatol Surg. 2016; 42(4):507-12. DOI: 10.1097/DSS.0000000000000653. View

18.

Gokalp H, Akkaya A, Oram Y . Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?. J Cosmet Dermatol. 2016; 15(4):420-426. DOI: 10.1111/jocd.12253. View

19.

Ranson M, Posen S, Mason R . Human melanocytes as a target tissue for hormones: in vitro studies with 1 alpha-25, dihydroxyvitamin D3, alpha-melanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol. 1988; 91(6):593-8. DOI: 10.1111/1523-1747.ep12477126. View

20.

Griffiths C, Finkel L, Hamilton T, Ellis C, Voorhees J . Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994; 130(6):727-33. View